Board Moves.

Abeona Therapeutics (NASDAQ: ABEO)

Appoints Bernhardt Zeiher and Eric Crombez to the Board of Directors. Mr. Zeiher Mr. Zeiher is the former Chief Medical Officer at Astellas Pharma and Mr. Crombez is the Chief Medical Officer Ultragenyx.

Alphatec (NASDAQ: ATEC)

Appoints Keith Valentine to the Board of Directors. Mr. Valentine is the former Chief Executive Officer at Orthofix.

Cencora (NYSE: COR)

Appoints Frank Clyburn to the Board of Directors. Mr. Clyburn is the former Chief Executive Officer at International Flavors & Fragrances.

Centene (NYSE: CNC)

Appoints Thomas Greco to the Board of Directors. Mr. Greco is the former Chief Executive Officer at Advance Auto Parts.

Clover Health Investments (NASDAQ: CLOV)

Appoints Thomas Tran to the Board of Directors. Mr. Tran is the former Chief Financial Officer at Upstream Care.

Compass Pathways (NASDAQ: CMPS)

Appoints Gino Santini to the Board of Directors. Mr. Santini is the former Senior VP Corporate Strategy & Business Development at Eli Lilly.

Corbus Pharmaceuticals (NASDAQ: CRBP)

Appoints Winston Kung to the Board of Directors. Mr. Kung is the Chief Financial Officer and Treasurer at ArriVent BioPharma.

Gyre Therapeutics (NASDAQ: GYRE)

Appoints David Epstein to the Board of Directors. Mr. Epstein is the Co-Founder and the Chief Executive Officer at PairX Bio.

Lifecore Biomedical (NASDAQ: LFCR)

Appoints Jason Aryeh, Paul Johnson, Humberto Antunes, and Matthew Korenberg to the Board of Directors. Mr. Aryeh is the Founder and Managing Partner at JALAA, Mr. Johnson is the Operations Partner at Ampersand Capital, Mr. Antunes is a Partner at Gore Range Capital, and Mr. Korenberg is the Chief Operating Officer at Ligand Pharma.

MannKind (NASDAQ: MNKD)

Appoints Steven Binder to the Board of Directors. Mr. Binder is the Executive Vice President, Special Projects at MannKind

National Vision (NASDAQ: EYE)

Appoints Caitlin Zulla to the Board of Directors. Ms. Zulla is the Group Division CEO at UnitedHealth.

Revolution Medicines (NASDAQ: RVMD)

Appoints Frank Clyburn to the Board of Directors. Mr. Clyburn is the former Chief Executive Officer at Int’l Flavors & Fragrances.

Select Medical (NYSE: SEM)

Appoints David Chernow to the Board of Directors. Mr. Chernow is the Chief Executive Officer at Select Medical.

SI-Bone (NASDAQ: SIBN)

Appoints Daniel Wolf to the Board of Directors. Mr. Wolf is the former Chief Strategy & M&A Officer at Baxter.

Trupanion (NASDAQ: TRUP)

Margaret Tooth promoted to CEO and she is appointed to the Board of Directors. Ms. Tooth is the former President at Allianz Insurance.

Warby Parker (NYSE: WRBY)

Appoints Bradley Singer to the Board of Directors. Mr. Singer is a former Partner and COO at ValueAct Capital.

‍

‍

Alignment Healthcare (NASDAQ: ALHC)

Jeffrey Margolis and Thomas Carella resign from the Board of Directors. Mr. Margolis is the former CEO, Chair of the Board and Founder at TriZetto and Mr. Carella is the Managing Director at Warburg Pincus.

Altimmune (NASDAQ: ALT)

David Drutz to leave the Board of Directors. Mr. Drutz is a former President at Pacific Biopharma Associates.

Beauty Health (NASDAQ: SKIN)

Julius Few resigns from the Board of Directors. Mr. Few is a Plastic Surgeon at The Few Institute and Founder of Dr. Few Skincare.

Eli Lilly (NYSE: LLY)

Marschall Runge retires from the Board of Directors. Mr. Runge is EVP for Medical Affairs at the University of Michigan, Dean of the Medical School, and CEO of Michigan Medicine.

Endo (OTCMKTS: NDOI)

Blaise Coleman resigns as CEO and from the Board of Directors. Mr. Coleman is the former Executive Director Finance at AstraZeneca.

Korro Bio (NASDAQ: KRRO)

David Lucchino resigns from the Board of Directors. Mr. Lucchino is the former Co-Founder and Chief Executive Officer at Frequency Therapeutics.

Notable Labs (NASDAQ: NTBL)

Thomas Bock resigns as CEO and from the Board of Directors. Mr. Bock is the former Founder, CEO & Chairman of the Board at HeritX.

NRx Pharmaceuticals (NASDAQ: NRXP)

Stephen Willard to resign as CEO and from the Board of Directors. Mr. Willard is the former Executive Director at Nozin.

Surmodics (NASDAQ: SRDX)

Ronald Kalich resigns from the Board of Directors. Mr. Kalich is the former Chief Executive Officer at FastenTech.